COPD Or Chronic Bronchitis That Was Dr Bruce Davies.

Slides:



Advertisements
Similar presentations
Chronic obstructive bronchitis and emphysema
Advertisements

Chronic Disease Management Beyond QoF Payments Dr Bruce Davies.
Frans H. Rutten, Nicolaas P. A. Zuithoff, EelkoHak, Diederick E. Grobbee, Arno W. Hoes Arch Intern Med. 2010;170(10): Beta-blockers may reduce.
New COPD GOLD Classification
Caring for Patients with COPD: Guidelines for Diagnosis and Management M. Elizabeth Knauft, MD MS September 20, 2007.
New Guidelines for COPD They keep changing. . . are you up to speed?
BY DR.Khaled Helmy Chest Specialist Al Mahmora Chest Hospital Ministry of Health - Egypt COPD SCOPE ON.
COPD Chronic Obstructive Lung Disease
Is it really COPD? Dr Rod Taylor Consultant Respiratory Physician Calderdale Royal Hospital Dr Rod Taylor Consultant Respiratory Physician Calderdale Royal.
or more simply.. -asthma is a condition of paroxysmal reversible airway obstruction which is characterised by : Airflow limitation ( reversible) Airway.
BACKGROUND & AIM THE IMPACT OF GERD ON EXACERBATIONS OF COPD HAS NEVER BEEN EVALUATED. TO DETERMINE THE PREVALENSI OF GER SYMPTOMS IN COPD PATIENTS.
Academy Board Prep PCCM
AHM 2011 Alyn Morice University of Hull HYMS COPD Disease not Disorder?
Respiratory Diseases Respiratory diseases cause problems with breathing and getting enough oxygen.
Physiology Lab Spirometry
นส. นุชนาถ ตั้งเวนิช เจริญสุข รหัส A chronic inflammatory disorder of the airway Airway hyperresponsiveness Recurrent episodes of wheezing,
2008 Guidelines 2.4 DIAGNOSIS IN ADULTS (1) -based on the recognition of a characteristic pattern of symptoms and signs and the absence of an alternative.
Dr. Danny Galdermans Dept Respiratory Medicine ZNA Middelheim Antwerp
Burden of COPD Société Belge de Pneumologie Belgische Vereniging voor Pneumologie Danny Galdermans.
CHRONIC OBSTRUCTIVE PULMONARY DISEASE COPD Juliana Tambellini University of Pittsburgh.
COPD (Chronic Obstructive Pulmonary Disease)
Chronic Obstructive Pulmonary Disease (COPD) Abtahi H, MD Packnejad, MD.
©LTPHN 2008 Respiratory Diseases Name Speaker. ©LTPHN 2008 Respiratory Disease – Global Burden Very common worldwide Substantial preventable morbidity.
Chronic Obstructive Pulmonary Disease Natasha Chowdhury.
Asthma A Presentation on Asthma Management and Prevention.
Definition of COPD COPD is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual.
Definition of COPD COPD is defined by GOLD (2014 update) as:*
22/06/2011.  Asthma – an introduction (Vanessa)  Diagnosis and management of chronic asthma in line with current BTS guidelines (Dr Lowery)  3 x Case.
Lung Volumes Inspiratory Reserve Volume:
COPD Review. Progressive Syndrome Expiratory airflow obstruction Chronic airway and lung parenchyma inflammation.
HEALTHY CARIBBEAN 2008 Revolutionizing the Prevention and Management of Lung Disease Dr. Timothy Roach FRCP FACP Head, Respiratory Unit Queen Elizabeth.
Chronic Obstructive Pulmonary Disease
Surveillance for Asthma: Measuring a Moving Target David M. Mannino Air Pollution and Respiratory Health Branch Centers for Disease Control and Prevention.
Respiratory Service Framework Asthma and COPD Care (Nursing) Project Learning and Development Strategy.
HSN Report Seniors October, Definition The Lottery is a tax on people who don’t understand statistics!!
WMMC Symposium. Centers For Disease Control What Is Chronic Obstructive Pulmonary Disease (COPD)?  COPD is the name for a group of diseases that restrict.
Asthma Diagnosis: Anatomy and Pathophysiology of Asthma Karen Meyerson, MSN, RN, FNP-C, AE-C Asthma Network of West Michigan April 21, 2009 Acknowledgements:
Chronic Obstructive Pulmonary Disease
Lung disorders Advanced Biology Stem Cells Forming An Artificial lung.
The Negative Impact of Air pollution on Respiratory Health Dr Des Murphy Consultant Respiratory Physician CUH.
COPD Diagnosis & Management Anil Ramineni Specialist Respiratory Physiotherapist Community Respiratory Team.
Home Care of Chronic Obstructive Pulmonary Disease Patients.
KEEP THEM BREATHING. WHAT IS NORMAL? EMERGENCIES.
Chronic Obstructive Pulmonary Disease Andrea Autry RRT MPH 500 Dr. Toland October
COPD Local Burden. Population Prevalence of GOLD Stage I and Stage II & Doctor Diagnosed COPD in Manila, Philippines Source: BOLD Study, 2007;Dantes R.
COPD ) ) Chronic Obstructive Pulmonary Disease. Introduction n COPD is a preventable and treatable disease with some significant extrapulmonary effects.
Disorders of the Respiratory System By : Amir Ashkan Ashrafian M.D.
Dr. Taj. What is Spirometry ? It is a measurement of the breathing capacity of the lungs. It is the most basic and frequently performed test of pulmonary.
CAPSTONE PROJECT. Setting the scene- why smoking cessation is important in the treatment of COPD.
Respiratory audit 318 referrals reviewed. Categories referred.
Chronic Obstructive Pulmonary Disease. COPD is an umbrella term for two diseases which cause progressive airflow obstruction Chronic Bronchitis- Inflammation.
Definition Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow limitation and a range of pathological changes in the lung.
Contents Key facts What is COPD Prevalence of COPD by age Hospitalisation trends Hospitalisation seasonality COPD deaths and smoking rates, COPD.
J R Hurst Thorax : Depart. Of Pulmonology R3 백승숙.
COPD SPUTUM PRODUCERS AND THE INFLUENCE ON ANTIBIOTIC RESISTANCE Sarah Thurston PhD student.
COPD 2003.
Chronic Obstructive Pulmonary Disease(COPD)
Health effects of intermittent fasting: hormesis or harm
Medicines Management – COPD update for LPC Jyoti Saini Hema Patel
Asthma-COPD Overlap Syndrome (ACOS) Challenges Diagnosing ACOS
Respiratory Disorders and Diseases
Chronic obstructive pulmonary disease (COPD)
Flow diagram of participants included in the survey. aResponse rate
Case Challenges in Chronic Migraine
Volume 97, Issue 1, Pages (January 1990)
COPD Chronic Obstructive Lung Disease
Chronic Obstructive Pulmonary Disease
WELCOME TO THE CME ON “CURRENT CONCEPTS IN THE MANAGEMENT OF COPD”
Prevalence of chronic obstructive pulmonary disease (COPD) defined by different criteria by region. The dark grey bar represents ‘symptom-based COPD’,
COPD Chronic Obstructive Lung Disease
Presentation transcript:

COPD Or Chronic Bronchitis That Was Dr Bruce Davies

Possible Areas to Cover Diagnosis Initial investigation Management plans Referral criteria Follow plans Troubleshooting The evidence base

Possible Areas to Cover Ideas for Audit Sources of further information Case Histories Future developments Prevalence Risk factors Prevention

Labels encompassed by COPD Chronic bronchitis Emphysema COAD Chronic airflow restriction Some cases of chronic asthma

Definition Chronic slowly progressive airways obstruction, not fully reversible FEV1 <80% predicted FEV1/FVC ratio <70% Impairment largely fixed

Prevalence Depends on where you work! Male:Female = 4:1 Urban:Rural = 2:1 5-25% of population Declining, or being redefined! 1-4 consultations per GP per week Strongly social class related Increases with age

Risk Factors Smoking Asthma Genetic Social class (Independent ? Of other factors) Pollution Occupational dust exposure Recurrent infection

Symptoms Smokers cough - Mild Breathlessness on exertion - Moderate Cough +/- sputum - Moderate Breathlessness on any exertion - Severe Peripheral oedema - Severe

Diagnosis Spirometry preferred to PEFR If PEFR used then it needs to be done over several weeks to confirm lack of variability CXR to exclude other problems Bronchodilators only give limited improvement of PEF

Management Plans Essential at all stages Quit rates improved by: I.Active cessation programmes II.NRT

Management Plans Exercise. Encouraged where at all possible, evidence that graded programmes are beneficial is growing.

Management Plans Obesity and poor nutrition make things worse

Management Plans Depression Common concurrent problem Social problems Also common

Management Plans Vaccination Influenza for all ? Pneumococcal

Management Plans i.Short acting Bronchodilator PRN or Anticholinergic MDI, PRN ii.Regular use of above iii.Combination of two

Management Plans ii.? Steroid trial iii.? Regular inhaled steroid, if positive response to trial iv.Assess for home nebuliser v.Assess for LTOT

Management Plans Probably useless Xanthines Long acting beta agonists

Steroid Trial 30mg prednisolone daily for 2 weeks + = 200ml increase in FEV1 from baseline Subjective improvement is negative Objective improvement in 10-20%

Referral Criteria Suspected severe COPD To confirm diagnosis & optimise therapy Onset of Cor pulmonale To confirm diagnosis & optimise therapy ? Need for oxygen therapy To measure blood gasses

Referral Criteria ? Nebuliser therapy To exclude inappropriate prescriptions Assessment for oral steroids To justify long term use / withdrawal supervision Bullous lung disease ? Surgery

Referral Criteria <10 pack years of smoking To confirm or exclude the diagnosis Rapid decline in FEV1 To encourage early intervention Aged less than 40 ? Alpha 1 anti-trypsin deficiency

Referral Criteria Uncertain diagnosis To make one! Symptoms disproportionate to lung function To look for other explanations

Acute Exacerbations Or Help

Features Worsening of previously stable state Increased dyspnoea Chest tightness Fluid retention Increased wheeze Increased sputum Increased sputum purulence

Assessment Able to cope at home? Good social circumstances? Cyanosis? Consciousness? Degree of breathlessness General condition? LTOT? Level of activity?

Home Treatment a.Increase bronchodilators b.7 day course of Abx c.Steroids for 1 week Consider: CXR, admission or referral if not back to normal in 2 weeks

Other Stuff

Evidence ? Rather good for these suggestions Very much a EBM field British Thoracic Society

References Thorax, 1997; 52(suppl 5): S1-S32 Common Diseases, Fry, MTP, 1995.

Prevention Fags Pollution Occupational factors ? Housing

Questions Should practices have spirometers? Or open access to lung function clinics? Should practice nurses run regular follow- up clinics? How should a practice audit this area? Should practices have smoking cessation clinics?